baber/WOPTO huggingface dataset:
Patent NZ-611197-A (NZ)
Title: Peripheral sensory and supersensory replacement system
Inventor: EVERETT BREANNE
IPC: A61B10/00
Filed: 2011-10-28
Abstract: A sensor-based quantification and analysis system and method are disclosed. The system comprises an input device, means for selecting and an output device. The input device includes a plurality of means for generating an input based on a force, and means for transmitting force information based on the input. The output device receives the force information. The means for selecting selects one of a plurality of levels of a likelihood of tissue damage based on a number of inputs within a predetermined time period indicating that a pressure threshold has been exceeded, for each of the plurality of means for generating an input. Each of the plurality of levels of the likelihood of tissue damage corresponding to a threshold percentage of inputs within the predetermined time period indicating that the pressure threshold has been exceeded. The output device includes display means that present or log the one of the plurality of levels of the likelihood of tissue damage for each of the plurality of means for generating. The means that generate an input comprise a plurality of sensors, and the means that that transmit force information based on the input comprise transmission means. Also disclosed is a sensor-based quantification and analysis system, comprising a shoe and an output device. The shoe includes a plurality of pressure sensors that sense a pressure, and a transmission device that wirelessly transmits force information based on the pressures. The output device that receives the force information and visually displays data based on the force information. A processing unit processes the force information to select one of a plurality of levels of a likelihood of tissue damage based on a number of inputs of the force information within a predetermined time period indicating that a pressure threshold has been exceeded, each of the plurality of levels of the likelihood of tissue damage corresponding to a threshold percentage of inputs within the predetermined time period indicating that the pressure threshold has been exceeded to produce the displayed data.
Patent NZ-615674-A (NZ)
Title: Packaging machine and process
Inventor: CHUBA LARRY
IPC: B65B43/26
Filed: 2011-05-09
Abstract: A conveyor system (16) pre-inserts a portion of a web (15) into a first belt before the portion is gripped between the first belt and a second belt. In one exemplary embodiment, a pair of lips of a web are inserted into a corresponding first pair of belts (40, 41) and then the pair of lips are secured in the first pair of belts by inserting a second pair of belts (48, 49) into the first pair of belts over the pair of lips.
Patent NZ-619855-A (NZ)
Title: A rotor assembly with a centrifugal de-clutch
Inventor: LONG GEOFFREY A
IPC: F16D43/18
Filed: 2012-11-14
Abstract: A rotor assembly comprising; a rotor (201), a motor, and a centrifugal de-clutch (100) coupled to the rotating part (203) of the motor. The centrifugal de-clutch comprising a plurality of friction pads and a monolithic ring including an inner circumference and an outer circumference, the monolithic ring formed to include a plurality of flexures extending circumferentially from the inner circumference in a same direction along the inner circumference of the monolithic ring. The plurality of flexures are configured to preload the plurality of friction pads against the stationary part (205) of the motor to resist rotation of the rotor below a speed threshold of the rotor to engage the centrifugal de-clutch; and wherein the plurality of flexures are configured to disengage the plurality of friction pads from the stationary part of the motor to allow the rotor to freely rotate above the speed threshold to disengage the centrifugal de-clutch.
Patent NZ-630029-A (NZ)
Title: Oral formulation for a medicament
Inventor: TAKEDA CHIKAKO
IPC: A61K47/42
Filed: 2013-04-30
Abstract: Provided are an oral formulation capable of improving easy administrability and showing good preservation stability, and a substrate for oral formulation. An oral formulation containing a medicament; sugar alcohol; one or more kinds of hydrophilic polysaccharides selected from the group consisting of acacia, pullulan and maltodextrin; a gelling agent; and water, and a substrate for oral formulation, which contains sugar alcohol; the above-mentioned hydrophilic polysaccharides; a gelling agent; and water.
Patent NZ-631236-A (NZ)
Title: Squash hybrid sv3451yg and parents thereof
Inventor: WILLIAM CLYDE JOHNSON
IPC: A01H4/00
Filed: 2014-09-11
Abstract: Further disclosed is a squash plant comprising at least a first set of chromosomes of squash line ZGN-EH10211 having been deposited under ATTC accession number PTA-121597. Disclosed is a squash hybrid SV3451YG, a sample of seed of said hybrid having been deposited under ATCC accession number PTA-121514. Further disclosed are seeds, plants and tissue cultures of said squash hybrid. Further disclosed are methods of producing and propagating said plants.
Patent NZ-700607-A (NZ)
Title: Surface modified stainless steel cathode for electrolyser
Inventor: KOZAK PAUL
IPC: C25B11/04
Filed: 2013-04-15
Abstract: Sodium chlorate is produced industrially via electrolysis of brine and is thus an energy intensive process. An improved cathode for this and other industrial processes is a low nickel content stainless steel whose surface has been suitably modified. With an appropriate amount of surface roughening, the cathode provides for improved overvoltages during electrolysis while still maintaining corrosion resistance.
Patent NZ-703717-A (NZ)
Title: Methods of upscaling mesenchymal stromal cell production, compositions and kit thereof
Inventor: DEVI DAMODARAN
IPC: C12N5/0775
Filed: 2015-01-09
Abstract: This invention relates to an improved process for culturing of bone marrow derived mesenchymal stromal cells, wherein one of the major technical features of the invention lies in the protocol devised to ensure uniform distribution of bFGF in the culture medium. This, along with the specific seeding and feeding schedule described therein, ensures efficient expansion of cell by at least 2000 fold within merely two consecutive passages. The process comprises the steps of: allowing the mesenchymal stromal cells cultured till a first predetermined passage, to expand to a second predetermined passage by consecutive passages in presence of culture media comprising uniform distribution of basic fibroblast growth factor (bFGF) at a concentration of about 2ng/ml; wherein said expansion is carried out by contacting the cells with said culture media when said cells achieve at least one pre-determined confluency; wherein the process increases number of the cells at the end of the second predetermined passage by at least 2000 folds when compared to number of the cells at the first predetermined passage; and wherein the first predetermined passage ranges from passage 3 to passage 8; and the second predetermined passage ranges from passage 5 to passage 10.
Patent NZ-713311-A (NZ)
Title: Segmentation of content delivery
Inventor: MULLINS BRIAN
IPC: G06T19/00
Filed: 2014-03-12
Abstract: An aspect of the invention provides systems and methods for segmentation of content delivery. Augmented reality (AR) is a live, direct or indirect, view of a physical, real-world environment whose elements are augmented by computer-generated sensory input such as sound, video, graphics or GPS data. Traditional AR technologies do not generate analytics results based on analytics data received from a plurality of devices in which the analytics results identifies a rate at which each feature of a three-dimensional model is interacted with and a rate at which each location on the three-dimensional model is viewed by the devices. A server of the invention comprises a memory configured to store a three-dimensional model of a virtual object; and a hardware processor implemented by a delivery segmentation module configured to divide the three-dimensional model into a plurality of segments, each segment of the three-dimensional model corresponding to a part of the virtual object, determine a position and an orientation of a device in relation to a physical object, divide the three-dimensional model into a first and a second segment of the plurality of segments based on the position and the orientation of the device in relation to the physical object, the first segment including parts of the virtual object visible from the device, the second segment including parts of the virtual object not visible from the device, generate analytics results based on analytics data received from a plurality of devices, the analytics results identifying a rate at which each feature of the three-dimensional model is interacted with and a rate at which each location on the three-dimensional model is viewed by the plurality of devices, divide the three-dimensional model into a third and a fourth segment of the plurality of segments based on the analytics results, a feature included in the third segment being interacted with more often than a feature included in the fourth segment, a location corresponding to the third segment being viewed more often than a location corresponding to the fourth segment, arrange an order of the plurality of segments in a delivery queue based on the analytics results or based on the position and the orientation of the device in relation to the physical object, the first segment being queued before the second segment in the delivery queue, the third segment being queued before the fourth segment in the delivery queue, and in accordance with the order of the delivery queue to the device that is configured to recognize the physical object that is associated with the three-dimensional model of the virtual object.
Patent NZ-717119-A (NZ)
Title: Aryl-or heteroaryl-substituted benzene compounds
Inventor: KUNTZ KEVIN WAYNE
IPC: C07D491/107
Filed: 2012-04-13
Abstract: Disclosed are N-((2-oxo-1,2-dihydropyridin-3-yl)methyl)-biphenyl-3-carboxamide derivatives of Formula (I) or a pharmaceutically acceptable salt thereof: wherein X1 is N or CR11; X2 is N or CR13; Z is NR7R8, OR7, S(O)nR7, or CR7R8R14; each of R1, R5, R9, and R10, independently, is H or optionally substituted alkyl; each of R2, R3, and R4 is independently H, or a substituent as defined herein; R6 is aryl or heteroaryl, each of which is optionally substituted; each of R8, R11, R12, and R13, independently is H, or a substituent; and wherein the remaining substituents are as defined herein. Representative compounds include 5-(cyclopentyl(methyl)amino)-N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-4’-((dimethylamino)methyl)-4-methyl-[1,1’-biphenyl]-3-carboxamide, 5-(cyclopentyl(methyl)amino)-N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-4-methyl-4’-(morpholinomethyl)-[1,1’-biphenyl]-3-carboxamide, 2-(cyclohex-1-en-1-yl)-N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-6-(4-((dimethylamino)methyl)phenyl)isonicotinamide, N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-(4-((dimethylamino)methyl)phenyl)-6-(piperidin-1-yl)isonicotinamide, N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-3-((tetrahydropyran-4-yI)(methyl)amino)-5-(1-(2-morpholinoethyl)-1H-pyrazol-4-yl)benzamide and 5-(tetrahydropyran-4-yI(ethyl)amino)-N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-4’-((morpholin-4-yl)methyl)-4-methyl-[1,1’-biphenyl]-3-carboxamide. Also disclosed is a pharmaceutical composition comprising a compound as defined above or a pharmaceutically acceptable salt thereof and a pharmaceutically acceptable carrier, for treating cancer, such as lymphoma, leukaemia, melanoma, prostate cancer, breast cancer, non-Hodgkin lymphoma, follicular lymphoma and diffuse large B-cell lymphoma.
Patent NZ-726501-A (NZ)
Title: Human monoclonal antibodies to ganglioside gd2
Inventor: SAWADA RITSUKO
IPC: C07K16/30
Filed: 2015-06-03
Abstract: The present invention provides compositions for the production of an antibody or functional fragment thereof directed against disialoganglioside-GD2. The compositions of the invention include polynucleotides encoding a heavy chain and/or a light chain variable domain that binds to GD2. The invention also provides an isolated antibody or functional fragment thereof and methods of treating or preventing a disease, such as cancer or tumor formation, wherein the antibody or functional fragment includes a variable heavy chain domain and a variable light chain domain that has an amino acid sequence provided herein. The invention further provides a conjugate of an antibody or functional fragment thereof conjugated or recombinantly fused to a diagnostic agent, detectable agent or therapeutic agent, and methods of treating, preventing or diagnosing a disease in a subject in need thereof.
Patent NZ-726740-A (NZ)
Title: Composition for enhancing memorization learning function and/or cognitive function
Inventor: ANO YASUHISA
IPC: A61K38/01
Filed: 2015-06-16
Abstract: Provided are a composition, food, and drug for enhancing memorization learning function and/or cognitive function, and for enhancing microglial phagocytotic and anti-inflammatory activities. Using a peptide including any one amino acid sequence of SEQ ID NOS: 1-16 as an active ingredient makes it possible to provide a composition, food, and drug for improving brain function, particularly for enhancing memorization learning function and/or cognitive function.
Patent NZ-731932-A (NZ)
Title: Crystalline forms of a bruton’s tyrosine kinase inhibitor
Inventor: PURRO NORBERT
IPC: A61K47/30
Filed: 2013-06-03
Abstract: Disclosed herein is a crystalline Form B of 1-((R)-3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)prop-2-en-1-one, wherein the crystalline form has an X-ray powder diffraction (XRPD) pattern comprising 2-Theta peaks at about 5.2°, about 10.2°, about 16.5°, about 18.5°, and about 20.8°. Also disclosed is a crystalline Form B of 1-((R)-3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)prop-2-en-1-one, wherein the crystalline form has an infrared (IR) spectrum with peaks at about 1586 cm-1, about 1573 cm-1, about 1562 cm-1, about 1229 cm-1, about 1141 cm-1, about 1103 cm-1, about 1056 cm-1, and about 1033 cm-1, and crystalline Form B of 1-((R)-3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)prop-2-en-1-one, wherein the crystalline form has a differential scanning calorimetry (DSC) thermogram having an endotherm having an onset at about 99 °C to about 106 °C with a peak at about 115 °C to about 118 °C. Further disclosed are formulations and medical uses of crystalline Form B.
Patent NZ-737474-A (NZ)
Title: Placental-derived stem cells to restore the regenerative engine, correct proteomic defects and extend lifespan
Inventor: HARIRI ROBERT
IPC: C12N5/071
Filed: 2016-05-27
Abstract: The present invention relates to the use of stem cells, such as placental-derived stem cells (PDSC), to reduce the effects of aging by, restoring the regenerative engine and extending the lifespan of aging subjects. Provided are methods for maintaining or increasing the ratio of the number of stem cells to the number of differentiated cells in a tissue of a subject over time, comprising administering to the subject an effective amount of a population of stem cells. Further provided are methods of maintaining or increasing the number of stem cells in a tissue of a subject over time, comprising administering to the subject an effective amount of a population of stem cells. Also provided herein are methods of altering the phenotype or proteome of an aging stem cell resident in a tissue of a subject, comprising administering to the subject an effective amount of a population of stem cells.
Patent NZ-740439-A (NZ)
Title: Animal dentistry training apparatus
Inventor: BENNETT MARIE-LOUISE AMANDA
IPC: G09B23/34
Filed: 2016-09-02
Abstract: The extraction of animal teeth with multiple roots is particularly complicated. Each of the roots of the tooth may diverge meaning that each root will have a different optimal direction for removal from its socket. So as to minimize the trauma caused to the adjacent tissues, multi-rooted teeth should first be sectioned into separate parts so that the tooth can be extracted as single root pieces one at a time. During training, veterinary practitioners only dedicate a limited amount of time to animal dentistry and so many veterinary practitioners are under prepared when it comes to performing a tooth extraction in practice. This leads to an increased rate of unsuccessful extractions and an increased rate of trauma for the animal patients. Provided is an animal dentistry apparatus comprising a sectioned artificial tooth (2), comprising a crown portion (4) and a furcate root portion (6), the furcate root portion comprising a plurality of roots (8, 10); and a base (20, 22) comprising a receiving portion configured to receive and releasably retain each root of the furcate root portion. The sectioned artificial tooth is sectioned into a plurality of sections comprising one or more but not all of said roots of the furcate root portion and part of the crown portion (14, 16), the plurality of sections being contiguous when the sectioned artificial tooth is received in the receiving portion. The sectioned artificial tooth is a substantial reproduction of a natural animal tooth and is sectioned in a manner representing the sectioning that facilitates removal of the corresponding natural tooth. The animal dentistry apparatus allows a user to assess and determine an approach for extracting an animal tooth by sectioning the tooth into individual roots from a living animal to help improve a practitioner’s technique for subsequent tooth extraction which thereby minimizes trauma to adjacent tissues.
Patent NZ-745190-A (NZ)
Title: Second generation superconducting filaments and cable
Inventor: SOLOVYOV VYACHESLAV
IPC: H01B12/06
Filed: 2017-01-20
Abstract: A method for manufacturing a multi-ply high-temperature superconducting wire from a second generation wire, the second generation wire including a superconducting layer positioned upon a metal substrate along with a buffer layer positioned between the superconducting layer and the metal substrate. The method comprises the steps of: separating the superconducting layer from the metal substrate to provide an exfoliated superconducting tape, the exfoliated superconducting tape including a superconducting layer in the absence of a buffer layer and a metal substrate; stacking lengths of the exfoliated superconducting tape; and laser slicing the stacked exfoliated superconducting tape into narrow strips to provide the multi-ply high-temperature superconducting wire, the multi-ply high-temperature superconducting wire having multiple superconducting layers.
Patent NZ-746330-A (NZ)
Title: Virtual numbers for intelligence operations
Inventor: BENNETT CHRISTOPHER
IPC: H04M1/72484
Filed: 2017-03-28
Abstract: Systems, methods, and computer readable storage mediums are configured for implementing virtual numbers (VN) for intelligence operations involving source-handler communications in support of an agency. Example embodiments implementing virtual numbers eschew the requirement of the agency to maintain and configure dedicated hardware switches that contain SIM card pairs to manage the transfer of source-handler calls in a compliant fashion. Rather than maintaining physical SIMs for each handler and each source with dedicated hardware, each source and each handler are assigned a virtual number for communicating in a compliant fashion. A source communicates with the handler through the handler VN and the hander communicates with the source through the source VN, and communications completed through the VNs are logged for compliance. Communications between a handler and a source may be permitted only when an association of their VNs exists in a mapping table to prevent unauthorized contact through the VNs.
Patent NZ-749326-A (NZ)
Title: Eicosapentaenoic acid (epa) formulations
Inventor: WAIBEL BRIAN J
IPC: A61P25/00
Filed: 2013-12-18
Abstract: Provided herein are methods of producing compositions comprising eicosapentaenoic acid (EPA) and polar lipids (e.g., glycolipids and phospholipids), and which do not contain any docosahexaenoic acid (DHA) or esterified fatty acids. The method involves extracting lipids from an algal paste comprising Nannochloropsis cells, removing the water-soluble components to yield a crude algal oil, extracting the free fatty acids with supercritical CO2 and isolating the fractions, and combining the concentrated EPA free fatty acid fraction with the polar lipid fraction.
Patent NZ-750137-A (NZ)
Title: Planar flexible rf tag and charging device
Inventor: FARKAS ALEXANDER T
IPC: H02J50/05
Filed: 2017-07-12
Abstract: A planar flexible RF tag (400) is disclosed which comprises: a flexible substrate; a planar complementary patch antenna (403) comprising first and second antenna patches (402(1), (402(2)) and a differential input (401). The first and second antenna patches (402(1), (402(2)) comprise metal positioned on one side of the flexible substrate and an RF transmitter circuit (422) is positioned on the flexible substrate and having a differential output (423) electrically coupled to the differential input.
Patent NZ-755143-A (NZ)
Title: Universal digital identity authentication service
Inventor: HUFFMAN RICHARD
Filed: 2018-02-16
Abstract: Consumers and businesses have adopted the use of online, digital interaction channels in performing financial, business, and transaction-related activities. As a result, accurately and securely authenticating individuals and protecting their private personally identifiable information (PII) is critical to all financial institutions and retailers. However, current digital authentication methods have significant weaknesses and pose security threats that place individuals, businesses, and government entities at risk. In addition to risks of interception of such information, banks, financial institutions, and other entities have found friction during the authentication process of users via mobile and other computing devices to be a leading cause of transaction or process abandonment. Increased risks and costs are associated with redundant and/or manual data capture, including captures associated with multiple registrations and logins for different websites, applications, and other online entry points. For consumers, friction during the authentication process can be burdensome and frustrating. Users may experience fears of repeated sharing of personal information at multiple websites and with multiple applications. The present disclosure involves systems and methods for identity authentication across multiple institutions using a trusted mobile device as a proxy for a user login. The operations include identifying a request to trust a particular user associated with a first entity in a digital ID network. A set of PII associated with the user is obtained via the first entity and an identity verification (IDV) /fraud risk analysis is performed. In response to satisfying the analysis, instructions are transmitted to the user to verify the identity via a mobile trust application on an associated mobile device. Upon verification, the mobile device is bound to the user within the digital ID network along with a digital ID associated with the particular user. The digital ID can be used by other entities registered within the digital ID network to authenticate the user.